Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: a systematic review and…

Overview of attention for article published in Frontiers in oncology, October 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 20,146 followers.

RT @FrontOncology: New research: Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment res…

30 Oct 2023

Reply Repost Favourite

Just published 🔔 Our paper on the biomarkers of immunotherapy . High levels of neutrophil- lymphocytes ratio (NLR) and Platelet-Lymphocyte ratio (PLR) shows response to immunotherapy drugs across several tumors. Link below ⬇️ @sitcancer https://t.co/LQm

29 Oct 2023

Reply Repost Favourite

RT @FrontOncology: New research: Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment res…

29 Oct 2023

Reply Repost Favourite

RT @FrontOncology: New research: Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment res…

29 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.